Pod Save America Hosts Call on Democrats to Cut All Israel Military Aid, No Longer Accept AIPAC Funding
Jews, Israelis Targeted in Austria Amid Surge in Antisemitic Incidents; Local Jewish Community Calls for Action
‘All of Our Strength’: Over 1,000 Pro-Israel Activists Gather in DC for Solidarity Conference
‘Devastated’: Wesley LePatner, Killed in Manhattan Mass Shooting, Was a Jewish Communal, Philanthropic Leader
Sen. Angus King Vows to No Longer Vote for Israel Military Aid Until Gaza Conditions Improve
Europe Won’t Pressure Israel to ‘Commit Suicide’ Amid Gaza Backlash, Palestinian State Push, Says Israeli FM
Israel’s National Soccer Coach Attacked in Athens Before Soccer Fans Chant ‘F–K Israel, Free Palestine’ at Match
New York Judge Sentences Neo-Nazi to 5 Years for Livestreaming Bomb Threats Against Jewish Hospitals
US Pressures Lebanon to Issue Cabinet Decision to Disarm Hezbollah Before Talks Continue
UK Plans to Recognize Palestinian State in September Unless Israel Meets Conditions, Starmer Says
Lab Meat Startup Future Meat Raises $14 Million
Error: Contact form not found.
by Adi Pick / CTech
Yaakov Nahmias, founder and chief scientist of Future Meat Technologies, holds laboratory-grown fat samples in his lab in Jerusalem on May 2, 2018. Photo: REUTERS/Ammar Awad.
CTech – Jerusalem-based lab-produced meat startup Future Meat Technologies has raised a $14 million series A funding round, the company announced Thursday, bringing its total funding to date to $16.2 million. The round was led by Chicago-based venture capital firm S2G Ventures and Switzerland-based Emerald Technology Ventures. Tyson Ventures, the venture arm of Tyson Foods, Henry Soesanto, the CEO of meat alternative company Monde Nissin, Manta Ray Ventures, and Shanghai-based venture capital firm Bits x Bites also participated in the round.
Founded in 2018, Future Meat develops technology for the GMO-free production of meat directly from animal cells, without the need to raise or slaughter animals. The company focuses on developing cost-efficient production of fat and muscle cells in small-scale rejuvenating bioreactors.
The company intends to use the funding to expand research and development efforts and build its cultured meat pilot production facility in the south of Tel Aviv, estimated to begin operations in 2020.
